PRAX
Praxis Precision Medicines Inc
NASDAQ: PRAX · HEALTHCARE · BIOTECHNOLOGY
$323.19
+0.39% today
Updated 2026-04-29
Market cap
$9.00B
P/E ratio
—
P/S ratio
953.14x
EPS (TTM)
$-13.47
Dividend yield
—
52W range
$35 – $356
Volume
0.4M
Praxis Precision Medicines Inc (PRAX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-20.72M | $-32.79M | $-52.62M | $-124.55M | $-185.04M | $-111.14M | $-131.76M | $-249.07M |
| Capital expenditures | $63000.00 | $103000.00 | $4000.00 | $1.05M | $444000.00 | $50000.00 | $0.00 | $56000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $579000.00 | $668000.00 | $5.21M | $22.69M | $28.59M | $24.86M | $41.36M | $33.94M |
| Free cash flow | $-20.78M | $-32.89M | $-52.63M | $-125.60M | $-185.49M | $-111.19M | $-131.76M | $-249.12M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $696000.00 | — | $811000.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $251.80M | $-157.49M | $-77.69M | — | — | — |